Socintec es la División de AZERTIA Company Profile

20:02 EST 16th December 2018 | BioPortfolio


News Articles [1 Associated News Articles listed on BioPortfolio]

Appian Corporation: Appian Provides New Digital Solution for Pharmacovigilance Reporting to Bayer

Solution Optimizes Processes for Increased Efficiency RESTON, Va. and FRANKFURT, Germany, June 28, 2018 (GLOBE NEWSWIRE) -- Appian (NASDAQ:APPN) today announced that Bayer's Pharmaceuticals divisi...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis

This is a prospective, open-label, single-dose, single-arm phase I-II study in which 15 patients diagnosed with gonarthrosis grade II-III (Kellgren and Lawrence) will enter the study with ...

More Information about "Socintec es la División de AZERTIA" on BioPortfolio

We have published hundreds of Socintec es la División de AZERTIA news stories on BioPortfolio along with dozens of Socintec es la División de AZERTIA Clinical Trials and PubMed Articles about Socintec es la División de AZERTIA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Socintec es la División de AZERTIA Companies in our database. You can also find out about relevant Socintec es la División de AZERTIA Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record